clodronate disodium: Clinical Trials

5 trials of clodronate disodium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4

Follow clodronate disodium: new trials by email Literature Review of clodronate disodium trials Research Report on clodronate disodium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Combined Pentoxifylline-tocopherol-clodronate vs Placebo in Radiation-induced Brachial Plexopathy
Pentoxifylline placebo, Pentoxifylline, Tocopherol acetate - Radiation Induced Brachial Plexopathy
Phase 3CompletedAssistance Publique - Hôpitaux de Paris592011-03-012017-12-08
S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307
clodronate disodium, demeclocycline hydrochloride, ibandronate sodium - Breast Cancer
WithdrawnSWOG Cancer Research Network2008-10-012013-04-10
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
clodronate disodium, ibandronate sodium, zoledronic acid - Breast Cancer
Phase 3CompletedSWOG Cancer Research Network60972005-07-012021-07-02
Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer
clodronate, placebo - Breast Cancer
Phase 3CompletedNSABP Foundation Inc33232001-01-012017-12-13
Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer
clodronate disodium, mitoxantrone hydrochloride, prednisone - Pain, Prostate Cancer
Phase 3CompletedNCIC Clinical Trials Group2271997-11-242020-04-03

Conditions studied

Breast Neoplasms (3)  ·  Pain (1)  ·  Prostatic Neoplasms (1)  ·  Radiation induced brachial plexopathy (1)

Sponsors

SWOG Cancer Research Network (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  NCIC Clinical Trials Group (1)  ·  NSABP Foundation Inc (1)

Countries

United States (2)  ·  Canada (1)  ·  France (1)

Top investigators

Alexander H Paterson, MD, FRCP (1)  ·  Carla I. Falkson, MD (1)  ·  Dawn Hershman, MD (1)  ·  Donald S. Ernst, MD, FRCPC (1)  ·  Elizabeth C. Dees, MD (1)  ·  James N. Ingle, MD (1)  ·  Julie R. Gralow, MD (1)  ·  Mark J. Clemons, MD (1)  ·  Norman Wolmark, MD (1)  ·  Robert B. Livingston, MD (1)  ·  Sylvie Delanian, MD, PhD (1)

Results publications

PMID 38979716, PMID 12149294, PMID 12814333, PMID 12947070, PMID 22704583, PMID 22742890, PMID 32929540, PMID 33270906

NIH funding

U10CA032102 (1)